Savara (SVRA) Interest & Investment Income (2009 - 2025)
Savara (SVRA) recorded Interest & Investment Income of $11,000 in Q1 2017, down 71.8% from $39,000 a year earlier and down 26.7% from the prior quarter.
Powered by 
Analysis
Savara (SVRA) Interest & Investment Income (2009 - 2025) Analysis & Trends
On a TTM basis, Savara's Interest & Investment Income came in at $93,000 as of Mar 31, 2017, down 33.1% year-over-year; for FY2016, it came in at $122,000, down 6.2% from FY2015.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 13.2% (FY2011 to FY2016).
- Across earlier years, Interest & Investment Income came in at $130,000 in FY2015 (+88.4%), $69,000 in FY2014 (+15.0%), $60,000 in FY2013 (-18.4%) and $73,560 in FY2012 (+12.2%).
- The Q1 2017 figure is the lowest quarterly Interest & Investment Income since Q2 2013.
- On a year-over-year basis, Interest & Investment Income has declined for three consecutive quarters, with growth averaging 20.6% over the last eight quarters.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 149.9% in Q3 2012, against a decline of 71.8% in Q1 2017 at the low end.
- Per Business Quant, the preceding three quarters came in at $15,000 (Q4 2016), $31,000 (Q3 2016) and $36,000 (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Savara | 1.09 Bn | 407.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 548,000.00 |
| Jun 30, 2025 | 921,000.00 |
| Mar 31, 2025 | 1.50 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 709,000.00 |
| Mar 31, 2023 | 765,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Dec 31, 2016 | 15,000.00 |
| Sep 30, 2016 | 31,000.00 |
| Jun 30, 2016 | 36,000.00 |
| Mar 31, 2016 | 39,000.00 |
| Dec 31, 2015 | 36,000.00 |
| Sep 30, 2015 | 32,000.00 |
| Jun 30, 2015 | 32,000.00 |
| Mar 31, 2015 | 30,000.00 |
| Dec 31, 2014 | 19,000.00 |
| Sep 30, 2014 | 18,000.00 |
API Access
Savara Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();